Federated Hermes
CTSO icon

Federated Hermes’s Cytosorbents Corp CTSO Stock Holding History

Federated Hermes’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25
Closed -$1K – 2248
2020
Q4 		$1K Sell
25
-2,595
-99% -$21.7K ﹤0.01% 2165
2020
Q3 		$21K Buy
2,620
+1,106
+73% +$9.98K ﹤0.01% 1888
2020
Q2 		$15K Buy
+1,514
New +$13.9K ﹤0.01% 1901

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Federated Hermes's CTSO Position: Q1 2021 in Review

Federated Hermes sold out of Cytosorbents Corp (CTSO) in Q1 2021, closing a stake of 25 shares — an estimated $1K sold.

Federated Hermes first reported a position in CTSO in Q2 2020 and held it in 3 quarters. The position peaked at $21K in Q3 2020. 96 funds tracked by Wall St. Rank hold CTSO as of Q1 2021.

  • Federated Hermes reported no remaining Cytosorbents Corp position as of Q1 2021 after selling out during the quarter.
  • Federated Hermes sold 25 Cytosorbents Corp shares in Q1 2021, an estimated $1K.
  • Federated Hermes first reported a position in Cytosorbents Corp in Q2 2020 and held it in 3 quarters.
  • Federated Hermes's Cytosorbents Corp position peaked at $21K in Q3 2020.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2021.

Based on Federated Hermes's 13F filing for Q1 2021, filed 13 May 2021.